ClinicalTrials.gg
Enrolling by invitationNCT07497633Updated Sep 23, 2026

Spontaneous Coronary Artery Dissection (SCAD) Avatar Study

An observational study in Spontaneous Coronary Artery Dissection, sponsored by Mayo Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Mayo Clinic · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Coronary Artery Dissection, Spontaneous · United States.

Planned enrollment
8th of 10
150 · median 675
Started
2026
with 2 others
Observational
10 of 13
6 open now
Registered
11th of 13
by date
Lead sponsor
8 of 13
Mayo Clinic

Among the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, this one is the 8th largest by planned enrollment of the 10 observational ones that give a count, is one of 3 that started in 2026, is one of 10 observational ones, and was the 11th registered.

Coronary Artery Dissection, Spontaneous

28 studies on the registry are indexed under Coronary Artery Dissection, Spontaneous; 18 are open to participants now.

Browse Coronary Artery Dissection, Spontaneous studies →

Open to participants now

8 of the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 13 Coronary Artery Dissection, Spontaneous studies recruiting now, 11 (85%) set no upper age limit and 1 (8%) stops at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate patient satisfaction, comfort, and trust in interacting with an avatar compared with speaking to a human clinician during a pre clinical visit.

03

Conditions studied

  • Spontaneous Coronary Artery Dissection
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Eligible SCAD patients will be identified once they have a confirmed Mayo Clinic SCAD Clinic appointment

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients scheduled for a SCAD appointment at Mayo Clinic

Exclusion criteria

Exclusion Criteria:

  • Not Applicable
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Video Avatar

    Other: Video Avatar Interview

  • Voice-Only Avatar

    Other: Voice-Only Avatar Interview

  • Human Interview

    Other: Human Interview

Interventions

  • OtherVideo Avatar Interview

    Patients will undergo a pre-visit interview with a Video Avatar (LLM powered digital interviewer presented with on-screen video)

  • OtherVoice-Only Avatar Interview

    Patients will undergo a pre-visit interview with a Voice-Only Avatar ( LLM-powered interviewer delivered without visuals)

  • OtherHuman Interview

    Patients will undergo a Human Interview conducted by trained Mayo personnel

06

What researchers measure

Primary outcomes

  1. Patient Satisfaction

    Patient satisfaction with the AI avatar (Visual/Voice and Voice only) will be assessed using a structured questionnaire completed after the AI-conducted pre-interview. Responses will be measured on a numeric Likert scale (1-5), with higher scores indicating greater satisfaction and comfort with the AI avatar interaction.

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for May 2028, 17 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Mar 27, 2026
StartEst.
Dec 2026
Primary completionEst.
May 2028
CompletionEst.
May 2028
Last update
Sep 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07497633
Lead sponsor
Mayo Clinic
Responsible party
Sharonne Hayes (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Mar 27, 2026
Start date
Dec 2026 (estimated)
Primary completion
May 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Sep 23, 2026

Study contacts

Sharonne Hayes, M.D
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion